Intelligent bio solutions' innovative drug screening technology now offered in new zealand

New york, oct. 24, 2023 (globe newswire) -- intelligent bio solutions inc. (nasdaq: inbs) (“inbs” or the “company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its expansion into the new zealand market, representing a significant milestone in the company's growth strategy for its intelligent fingerprinting drug screening system.
INBS Ratings Summary
INBS Quant Ranking